phase 1_2_completion
saveNovartis AG — zigakibart (Phase I/II Trial Completion)
community read0 votes
Therapy area: Genito Urinary System. Indication: IgA Nephropathy (Berger's Disease)
Data sources
globaldata
Found something off?
same company · ±60 days · 6
- earningsNOVARTIS AG earningsApr 28, 2026
- phase 2 initiationasciminib hydrochloride: Novartis AG — asciminib hydrochloride (Phase II Trial Initiation)Apr 25, 2026
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalApr 17, 2026
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalApr 17, 2026
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalApr 17, 2026
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalApr 17, 2026
comments(0)
5-min edit window · permanent after that